Melanocytic naevi of trunk

CD2_BENIGN_MELANOCYTIC_TRUNK

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.5& Hospital discharge: ICD-9 — 2165A Cause of death: ICD-10 — D22.5& Cause of death: ICD-9 — 2165A 2 out of 7 registries used, show all original rules.	4886
4. Check minimum number of events None	4886
5. Include endpoints None	4886
6. Filter based on genotype QC (FinnGen only)	4886

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus (cutis) trunci

NAME	CD2_BENIGN_MELANOCYTIC_TRUNK
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D225
HD_ICD_9	2165A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D225
COD_ICD_9	2165A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of trunk based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Melanocytic naevi of trunk

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	29275	16097	13097
Only index persons	27901	15497	12404
Unadjusted period prevalence (%)
Whole population	0.42	0.46	0.37
Only index persons	0.53	0.57	0.47
Median age at first event (years)
Whole population	44.81	41.41	49.03
Only index persons	45.35	41.84	49.74

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4886	2900	1986
Unadjusted period prevalence (%)	0.94	0.99	0.88
Median age at first event (years)	51.66	45.48	60.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4300: Matched controls
42999

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

9.1

323.0

1257

1873

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

27.4

323.0

1915

1225

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1279.0

323.0

4130

801

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

9.2

290.6

649

814

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.8

242.0

759

1532

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

36.6

206.6

268

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

6.1

196.3

577

1057

L57.0

ICD-10 Finland

Actinic keratosis

5.0

192.1

688

1588

2165A

ICD-9 Finland

Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

184.7

176

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

8.5

172.8

399

512

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

12.9

164.8

302

250

XQ845

NOMESCO Finland

Dermatoscopy

17.6

164.1

264

159

TQW99

NOMESCO Finland

Other minor procedure on skin

6.0

144.8

427

773

L82

ICD-10 Finland

Seborrhoeic keratosis

3.1

140.0

891

3312

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

11.5

138.9

269

249

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

8.8

138.2

309

373

XQ848

NOMESCO Finland

Dermatological photography

8.8

137.0

308

375

R23.8

ICD-10 Finland

Other and unspecified skin changes

3.0

133.3

918

3588

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

25.5

132.4

188

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

5.0

127.2

443

970

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

8.2

125.0

293

381

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

8.4

116.6

268

337

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

28.9

116.1

159

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

27.0

114.0

159

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

10.9

98.4

194

185

D03.5

ICD-10 Finland

Melanoma in situ of trunk

37.5

91.2

117

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

67.2

90.9

105

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

17.3

89.6

144

PJA12

NOMESCO Finland

Sentinel node biopsy

3.5

86.9

447

1385

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

9.3

85.8

184

205

S18

ICPC

Laceration/cut

1.9

79.7

1800

11884

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

6.5

72.8

197

314

127

Kela drug reimbursment

Transplant complication

7.7

72.5

175

237

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

3.7

72.3

335

948

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

5.9

66.8

194

339

ZXC50

NOMESCO Finland

Cryotherapy

5.6

65.6

199

367

9733

FHL

Excision of skin change in operating room or anesthesia

8.1

61.2

142

181

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

5.6

57.4

173

317

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

13.8

57.2

100

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

34.2

56.8

Z94.0

ICD-10 Finland

Kidney transplant status

8.3

56.3

128

158

Z2221

NOMESCO Finland

Medical doctor

1.8

55.8

1254

8008

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

13.1

55.5

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

7.0

53.8

137

201

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

17.1

52.5

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.9

50.3

SPAT1153

SPAT

Removal of sutures

1.7

49.5

1299

8643

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

5.0

49.2

163

333

L04AA06

ATC

mycophenolic acid; systemic

5.5

48.1

147

274

ZZR00

NOMESCO Finland

Flap of skin

5.1

47.5

157

320

S82

ICPC

Naevus/mole

2.1

45.4

573

2929

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

5.4

45.2

140

265

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

19.7

44.8

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

26.2

44.6

L04AD01

ATC

ciclosporin; systemic

4.8

43.8

152

327

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

6.1

43.3

121

202

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

6.9

43.2

110

162

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

23.0

40.9

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

8.2

40.3

115

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

21.0

39.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

39.0

1516

11039

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

18.4

37.5

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.7

37.3

116

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.3

37.1

144

347

C43

ICD-10 Finland

Malignant melanoma of skin

29.1

36.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

3.8

36.1

158

425

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.0

35.7

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

33.2

35.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

9.9

34.9

D22

ICD-10 Finland

Melanocytic naevi

2.7

34.5

245

932

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.2

34.4

135

329

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

17.3

33.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

10.5

33.0

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

74.7

32.9

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

32.1

1068

7407

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.8

32.0

123

ZXA05

NOMESCO Finland

Left side

1.6

31.9

930

6228

137

Kela drug reimbursment

Uraemia requiring dialysis

6.6

31.9

127

D06BB10

ATC

imiquimod; topical

2.7

31.7

229

881

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

31.6

1398

10359

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

16.1

31.5

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

11.5

31.5

ZXC15

NOMESCO Finland

Use of photodynamic technique

6.6

30.5

124

R4110

NOMESCO Finland

Physiotherapy

1.6

30.2

1001

6917

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

11.1

29.9

ZXA00

NOMESCO Finland

Right side

1.6

29.3

975

6734

L04AA01

ATC

[U] ciclosporin; systemic

4.4

27.8

103

239

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

16.5

27.5

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.8

26.9

L04AX01

ATC

azathioprine; systemic

2.5

26.6

213

870

Z3231

NOMESCO Finland

Registered nurse

1.5

26.6

1048

7508

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

16.3

26.2

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.3

26.0

137

429

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

21.3

26.0

J01DB01

ATC

cefalexin; oral

1.5

25.6

3339

30133

A11CC03

ATC

alfacalcidol; systemic

3.4

25.6

126

375

ZXC20

NOMESCO Finland

Use of chemical agents

4.2

25.1

240

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

9.5

24.9

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

5.4

24.8

144

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

11.0

24.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

24.7

1544

12128

ZXE00

NOMESCO Finland

One hour or less

1.4

24.6

1539

12081

A12AA04

ATC

calcium carbonate; oral

4.1

24.2

243

E0000UV

ATC

1.4

23.9

1514

11903

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

23.7

135

446

Z3226

NOMESCO Finland

Physiotherapist

1.6

23.7

691

4589

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

7.3

22.9

B07.9

ICD-10 Finland

Verruca simplex

2.7

22.7

163

625

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

40.3

22.6

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

12.6

22.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

22.3

496

3053

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

22.3

185

770

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

35.2

22.0

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.9

21.8

104

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

21.7

1035

7668

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.4

21.5

108

328

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

6.8

21.5

180

Kela drug reimbursment

Interferon alfa

12.4

21.3

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

7.8

21.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

20.9

657

4429

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

20.9

775

5435

D22.0

ICD-10 Finland

Melanocytic naevi of lip

11.6

20.7

S29

ICPC

Skin symptom/complaint other

1.6

20.7

612

4067

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

7.4

20.6

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

17.0

20.4

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

11.3

20.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

20.4

239

1174

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

6.0

20.4

L91.0

ICD-10 Finland

Hypertrophic scar

4.0

20.3

208

B05DA

ATC

Isotonic solutions

5.7

20.3

102

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.7

20.3

148

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

6.0

20.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

19.9

977

7259

L01XE23

ATC

[U] dabrafenib; oral

31.4

19.2

TK800

NOMESCO Finland

Hemodialysis

3.1

18.9

105

345

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

4.8

18.4

128

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

8.4

18.4

Z94.4

ICD-10 Finland

Liver transplant status

9.6

18.3

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

18.3

1243

9780

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

18.2

245

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.0

17.7

245

1286

B05DB

ATC

Hypertonic solutions

6.1

17.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

17.6

1359

10903

S77

ICPC

Malignant neoplasm of skin

4.7

17.3

124

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.5

17.2

138

ZXD20

NOMESCO Finland

Day surgery

1.6

17.1

465

3016

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

17.0

272

1505

UKC02

NOMESCO Finland

Cystoscopy

1.6

17.0

509

3383

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

16.9

224

1156

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

17.4

16.9

N02BE01

ATC

paracetamol; systemic, rectal

1.4

16.8

3377

31212

Z49.2

ICD-10 Finland

Other dialysis

5.3

16.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

16.6

213

1088

DAB00

NOMESCO Finland

Excision of lesion of auricle

5.1

16.5

100

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

6.8

16.5

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

20.1

16.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

7.6

16.1

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

15.9

470

3112

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

15.9

181

878

J01MA02

ATC

ciprofloxacin; systemic

1.3

15.9

1338

10840

WX110

NOMESCO Finland

Local anesthesy

1.3

15.7

2715

24360

QBA10

NOMESCO Finland

Incision of skin of trunk

3.9

15.7

166

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

9.2

15.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

15.6

752

5537

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

22.1

15.5

L03AB05

ATC

interferon alfa-2b; parenteral

10.8

15.4

ZX120

NOMESCO Finland

Intravenous

1.7

15.3

328

1993

WX002

NOMESCO Finland

Sedation and analgesia

1.5

15.3

657

4725

ZXA10

NOMESCO Finland

Bilateral

1.5

15.3

623

4434

UJF32

NOMESCO Finland

Coloscopy

1.4

15.2

843

6364

HA1AA

NOMESCO Finland

X-ray mammography

1.9

15.2

240

1325

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

15.0

570

3994

A98

ICPC

Health maint/preventive medicine

1.7

15.0

4067

39203

Z31.5

ICD-10 Finland

Genetic counselling

2.0

15.0

201

1045

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

14.0

15.0

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

8.9

14.9

H02AB04

ATC

methylprednisolone; systemic

1.5

14.8

500

3411

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.4

14.8

127

539

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

6.2

14.8

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

13.2

14.7

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.5

14.7

117

480

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

21.1

14.6

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

21.1

14.6

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.4

14.5

120

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.9

14.4

316

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

14.2

171

853

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

9.7

14.2

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

14.2

1036

8183

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.1

13.9

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

30.1

13.9

J05AB11

ATC

valaciclovir; oral

1.5

13.8

451

3055

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

4.4

13.8

112

WX402

NOMESCO Finland

General anaesthesia

1.5

13.8

583

4172

ZZA00

NOMESCO Finland

Split skin graft

2.5

13.8

109

447

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

13.6

251

1458

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.9

13.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

13.5

342

2178

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

25.8

13.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.9

13.3

140

DHB00

NOMESCO Finland

Excision of lesion of external nose

4.3

13.3

112

J01CA04

ATC

amoxicillin; systemic

1.3

13.2

3244

30114

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

13.2

111

470

TK820

NOMESCO Finland

Peritoneal dialysis

6.1

13.1

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

7.5

13.1

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

12.9

125

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

19.1

12.9

JN4BD

NOMESCO Finland

Extensive body CT

1.6

12.8

357

2328

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

12.7

1910

16607

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.3

12.7

115

506

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.7

814

6276

A02BC01

ATC

omeprazole; systemic

1.3

12.7

910

7145

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

6.3

12.7

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

12.7

685

5134

S21

ICPC

Skin texture symptom/complaint

1.5

12.7

419

2847

TQW40

SPAT

2.2

12.7

122

553

A02BC02

ATC

pantoprazole; systemic

1.3

12.6

2315

20628

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

12.6

200

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

15.4

12.6

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

3.8

12.6

138

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

12.5

307

1935

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

8.2

12.5

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

130.4

12.4

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

12.4

369

2444

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

12.3

373

K07.60

ICD-10 Finland

Snapping jaw

1.9

12.3

189

1033

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

4.2

12.3

107

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

12.3

404

2739

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

12.3

771

5924

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.4

12.2

167

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

9.6

12.2

V03AE01

ATC

polystyrene sulfonate; oral

3.5

12.2

157

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.0

12.1

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

6.4

12.1

Z2446

NOMESCO Finland

Social worker

1.7

12.0

232

1366

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.0

12.0

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

13.4

11.9

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

6.4

11.8

J01FA10

ATC

azithromycin; systemic

1.3

11.8

2229

19856

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

11.6

418

2889

R31

ICD-10 Finland

Unspecified haematuria

1.6

11.6

297

1894

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

19.0

11.6

L01XE25

ATC

[U] trametinib; oral

22.9

11.6

4056

NOMESCO Finland

22.9

11.6

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.9

11.5

119

D07AC01

ATC

betamethasone; topical

1.3

11.4

1164

9595

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

13.6

11.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.1

11.4

121

574

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

11.4

184

1026

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

3.8

11.3

126

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

4.7

11.3

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

35.1

11.3

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.9

11.2

B03XA01

ATC

erythropoietin; parenteral

4.0

11.2

112

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

17.1

11.2

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

12.7

11.1

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

11.0

383

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

11.0

238

1449

J01AA02

ATC

doxycycline; systemic

1.3

11.0

2907

26820

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

10.9

258

1613

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

15.5

10.8

J05AB01

ATC

aciclovir; systemic

1.3

10.8

716

5542

D06BX02

ATC

ingenol mebutate; topical

3.5

10.7

137

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

10.6

152

814

7151

FHL

Kidney transplantation

11.2

10.5

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.1

10.5

121

595

H02AB09

ATC

hydrocortisone; systemic

2.4

10.4

370

L72.1

ICD-10 Finland

Trichilemmal cyst

1.7

10.4

205

1220

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

10.3

112

537

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

10.2

263

1682

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

10.1

125

632

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

13.1

10.1

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.5

10.1

306

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.1

10.1

177

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.8

10.0

218

JJ5AT

NOMESCO Finland

14.6

10.0

J02AC01

ATC

fluconazole; systemic

1.2

9.9

1441

12369

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.4

9.9

420

3001

C08CA01

ATC

amlodipine; oral

1.3

9.9

1025

8443

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

12.2

9.8

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.6

9.8

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.9

9.7

198

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

9.7

255

1641

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

6.8

9.6

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.5

9.6

363

2539

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

9.6

365

D07AD01

ATC

clobetasol; topical

1.4

9.5

495

3676

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

9.5

151

840

XKD00

NOMESCO Finland

Uroflowmetry

1.4

9.5

470

3459

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

10.0

9.5

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

6.6

9.4

K06.18

ICD-10 Finland

Another gingival hyperplasia

6.6

9.4

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

4.0

9.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

9.4

363

9734

FHL

Excision and local plastic or associated free skin grafting

3.9

9.4

B01AB05

ATC

enoxaparin; parenteral

1.3

9.3

952

7818

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

9.3

1259

10705

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

9.2

307

2092

R01AD09

ATC

mometasone; nasal

1.2

9.2

1638

14347

130

Kela drug reimbursment

Malignant tumour

1.6

9.2

234

1494

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.1

952

7837

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

9.1

572

4380

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

9.1

1008

8358

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.0

9.1

117

604

F16

ICPC

Eyelid symptom/complaint

1.8

9.0

148

830

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

5.9

9.0

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

9.0

390

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

5.6

9.0

L02BA01

ATC

tamoxifen; oral

2.0

9.0

117

607

5602

FHL

Internal fistula (eg Cimino)

36.8

9.0

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

9.0

125

665

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.6

9.0

246

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

8.9

304

2078

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

18.6

8.9

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.9

1053

8799

A02BC05

ATC

esomeprazole; systemic

1.2

8.9

1347

11584

V03AE02

ATC

sevelamer; oral

4.3

8.9

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

8.9

561

4303

D10BA01

ATC

isotretinoin; oral

1.6

8.7

228

1464

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

5.3

8.7

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.4

8.7

293

Z01.7

ICD-10 Finland

Laboratory examination

1.4

8.7

352

2492

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

8.7

1862

16592

C03CA01

ATC

furosemide; systemic

1.3

8.7

728

5821

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

8.6

1288

11051

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.2

8.6

368

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.6

8.6

244

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

8.6

188

1156

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.7

8.6

204

3AC01

NOMESCO Finland

3.0

8.5

159

XF404

NOMESCO Finland

Ambulatory ECG

1.5

8.5

278

1886

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.5

1188

10119

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.4

8.5

116

D01AE16

ATC

amorolfine; topical

1.4

8.5

350

2491

N18.0

ICD-10 Finland

End-stage renal disease

2.9

8.4

170

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

3.4

8.4

111

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

8.4

159

933

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

5.6

8.4

BE00A

NOMESCO Finland

90.2

8.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.6

8.4

232

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

8.3

332

2345

5AB14

NOMESCO Finland

7.9

8.3

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

8.3

256

1713

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.1

8.3

439

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.3

219

1411

205

Kela drug reimbursment

Chronic hypertension

1.3

8.3

753

6077

D02AX

ATC

Other emollients and protectives

1.9

8.3

111

582

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.5

8.3

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

8.2

321

2259

WW200

NOMESCO Finland

Immunization

2.0

8.2

106

548

115

Kela drug reimbursment

Breast cancer

1.6

8.2

221

1435

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

4.9

8.2

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

8.2

184

1140

S26

ICPC

Fear of cancer of skin

3.1

8.1

137

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

2.9

8.0

165

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

8.0

471

3568

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

5.2

8.0

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.7

7.9

145

846

ZX197

NOMESCO Finland

13.0

7.9

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1.8

7.8

125

701

TQW20

NOMESCO Finland

Tatoe

2.9

7.8

147

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

6.9

7.8

3016

Kela drug reimbursment

Binimetinib and encorafenib

45.0

7.7

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

5.5

7.7

ZZA50

NOMESCO Finland

Full thickness skin graft

4.7

7.6

TQB05

NOMESCO Finland

Puncture of skin of trunk

3.2

7.6

121

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

7.6

1678

L01BB01

ATC

6.2

7.5

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

10.0

7.5

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

7.1

7.5

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

7.4

245

1668

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

7.4

119

665

R51.80

ICD-10 Finland

Headache

1.3

7.4

488

3764

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.9

7.3

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

4.7

7.3

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

4.3

7.2

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.2

1007

8553

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

7.2

498

3871

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

7.2

194

1263

187

Kela drug reimbursment

MPA

30.0

7.1

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

7.1

116

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

7.1

253

1746

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

20.0

7.1

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

7.1

1010

8588

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

7.1

105

572

ICD-10 Finland

2.1

7.1

359

L04AA05

ATC

[U] tacrolimus; systemic

12.0

7.1

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

7.0

239

1639

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

10.0

7.0

B35.1

ICD-10 Finland

Tinea unguium

1.6

7.0

169

1069

C02AC05

ATC

moxonidine; oral

1.7

7.0

123

712

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

7.0

S97

ICPC

Chronic ulcer skin

1.7

7.0

144

874

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

6.9

379

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

6.9

391

2944

S15

ICPC

Foreign body in skin

1.6

6.9

182

1177

D07AB08

ATC

desonide; topical

1.4

6.9

339

2494

C09CA06

ATC

candesartan; oral

1.3

6.9

646

5235

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

6.8

265

1867

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.9

6.8

538

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

2.6

6.8

189

R50.9

ICD-10 Finland

Fever, unspecified

1.3

6.8

437

3357

C08CA13

ATC

lercanidipine; oral

1.4

6.8

337

2482

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.5

6.8

208

1513

Kela drug reimbursment

Binimetinib and encorafenib

40.1

6.8

Z94.1

ICD-10 Finland

Heart transplant status

5.6

6.7

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

16.7

6.7

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.2

6.7

276

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

6.7

262

1845

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.7

104

579

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

6.7

288

2066

ZX108

NOMESCO Finland

Inhalation

3.5

6.7

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.5

6.7

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

22.5

6.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.7

167

1069

XF402

NOMESCO Finland

ECG with work load test

1.4

6.6

307

2237

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

12.2

6.6

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

6.6

618

5007

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.6

645

5253

WXQ99

NOMESCO Finland

Other light therapy

8.7

6.5

D07XC01

ATC

betamethasone, combinations; topical

1.4

6.5

354

2645

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.5

2430

22535

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

10.0

6.5

L84

ICD-10 Finland

Corns and callosities

1.8

6.5

525

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.3

6.5

258

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

5.7

6.4

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

7.4

6.4

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.4

6.4

203

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.1

6.4

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

6.4

177

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

6.4

1425

12644

C08CA02

ATC

felodipine; oral

1.5

6.4

239

1672

XF612

NOMESCO Finland

Measurement of central venous pressure

5.2

6.3

BAA60

NOMESCO Finland

Total thyroidectomy

1.9

6.3

424

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

6.3

244

1719

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.4

6.3

216

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.5

6.3

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

9.3

6.3

J01FA06

ATC

roxithromycin; oral

1.2

6.3

1341

11842

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.5

6.3

188

6119

FHL

Other measure in this category

18.0

6.3

QB5S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in back

18.0

6.3

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.3

293

2139

D18.0

ICD-10 Finland

Haemangioma, any site

2.0

6.3

375

KAS40

NOMESCO Finland

Excision of transplanted kidney

+∞

6.2

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

6.2

286

2078

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

6.2

311

2294

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.2

2677

25078

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

2.4

6.2

208

D02AE01

ATC

carbamide; topical

1.5

6.2

211

1450

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.2

1109

9636

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

5.3

6.1

H02AB06

ATC

prednisolone; systemic

1.2

6.1

1565

14035

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

6.1

284

2070

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.5

6.1

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

4.0

6.1

G04CA02

ATC

tamsulosin; oral

1.3

6.0

597

4861

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

6.7

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1442

5161

3.55

322.70

1.8

1.3

—

(40768804) Tissue Pathology biopsy report

2949

16393

3.02

302.26

3.2

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

137

175

8.03

100.48

27.8

25.2

ug/l

97.7

110.7

1.35

119

145

(40768443) Skin Pathology biopsy report

463

1636

3.02

97.57

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

123

167

7.53

85.58

34.9

34.5

ug/l

6.8

7.5

2.07

104

152

(4035726)

702

3299

2.32

82.33

1.6

1.4

—

(3001604) Monocytes [#/volume] in Blood

2597

20159

1.62

57.08

8.2

5.8

e9/l

0.6

0.21

2304

17520

(3006315) Basophils [#/volume] in Blood

2605

20238

1.62

57.05

8.2

5.9

e9/l

0.0

0.52

2311

17583

(3019198) Lymphocytes [#/volume] in Blood

2659

20782

1.61

56.62

8.1

5.9

e9/l

1.9

0.09

2398

18427

(3013115) Eosinophils [#/volume] in Blood

2661

20945

1.59

53.83

8.4

6.1

e9/l

0.2

0.97

2395

18507

(3013650) Neutrophils [#/volume] in Blood by Automated count

2897

23280

1.60

53.55

11.5

8.9

e9/l

3.9

4.1

4.14

2591

20386

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

744

4220

1.90

51.08

5.9

4.2

u/l

238.0

242.1

0.21

714

3990

(3024561) Albumin [Mass/volume] in Serum or Plasma

2154

16299

1.58

50.40

6.9

4.8

g/l

36.3

35.8

4.38

2056

15184

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

224

796

2.90

46.16

8.3

5.5

iu/ml

830.9

2763.5

0.42

102

(3019420) Tryptase [Mass/volume] in Serum or Plasma

103

217

4.83

45.77

1.2

1.5

ug/l

5.7

8.9

1.99

187

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

144

5.56

41.35

3.1

2.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

507

2708

1.97

41.13

6.7

3.8

ng/l

106.2

87.0

3.63

465

2379

(42870588) Differential panel, method unspecified - Blood

1802

13564

1.52

40.43

8.0

5.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3496

30199

1.55

40.29

10.2

7.4

u/l

75.3

77.0

1.44

3340

28534

(3002385) Erythrocyte distribution width [Ratio]

3885

34401

1.63

40.16

21.4

15.8

13.6

0.23

3826

33692

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.85

40.15

5.3

6.1

—

(3019069) Monocytes/100 leukocytes in Blood

2376

19045

1.48

38.60

8.7

6.3

8.5

0.05

2280

17886

(3002030) Lymphocytes/100 leukocytes in Blood

2434

19635

1.48

38.09

8.5

6.0

28.5

28.4

0.37

2325

18356

(3006504) Eosinophils/100 leukocytes in Blood

2361

18941

1.48

37.94

8.5

6.0

2.9

2.8

0.16

2246

17680

(3018010) Neutrophils/100 leukocytes in Blood

2404

19365

1.48

37.77

8.2

5.9

57.0

0.01

2296

18165

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2334

18702

1.47

37.61

10.0

6.5

mmol/l

1.2

0.46

2031

15828

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

974

6489

1.63

36.80

3.3

2.7

e6/l

1.3

1.1

0.24

603

3644

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

247

1036

2.46

36.59

7.2

3.4

mg/l

1.7

1.5

3.53

233

959

(3033658) Prothrombin time (PT) actual/Normal

1374

9925

1.53

36.52

5.0

3.9

91.8

91.3

0.30

1346

9670

(3022096) Basophils/100 leukocytes in Blood

2291

18369

1.47

36.33

8.7

6.0

0.7

0.42

2188

17164

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

632

2.87

36.16

4.6

2.7

u/ml

625.6

1542.8

0.58

(3018095) Leukocytes [#/volume] in Urine

1809

13892

1.48

35.54

4.9

3.6

e6/l

47.5

93.9

1.52

1331

9655

(3002582) Erythrocytes [#/volume] in Urine

1566

11689

1.50

35.39

4.4

3.2

e6/l

40.2

84.8

2.88

1240

8938

(3003458) Phosphate [Moles/volume] in Serum or Plasma

770

4884

1.68

35.10

11.6

5.9

mmol/l

1.1

1.0

1.01

729

4569

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2462

20117

1.45

34.74

8.0

6.1

umol/l

11.0

11.2

0.34

2345

19071

(3021589) Normoblasts [#/volume] in Blood

2235

17933

1.45

34.73

11.5

9.1

e9/l

0.0

0.59

1825

14681

(3018418) pH of Serum or Plasma

1489

11044

1.50

34.52

6.5

3.9

7.4

1.89

233

2130

(3030467) Casts [#/volume] in Urine by Automated count

1448

10709

1.50

33.92

4.2

3.1

e6/l

0.3

0.4

1.06

1117

8034

(3020779) Urea [Moles/volume] in Serum or Plasma

564

3323

1.79

33.36

14.4

7.6

mmol/l

10.3

9.4

2.50

545

3184

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2115

16899

1.44

33.04

8.5

5.8

mmol/l

1.2

0.47

1967

15369

(3013707) Erythrocyte sedimentation rate by Westergren method

3395

29700

1.47

31.94

4.7

3.9

mm/h

10.9

11.2

0.81

3173

27675

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

895

6064

1.58

30.91

3.5

2.9

e6/l

2.0

2.6

1.61

527

3234

(3000850) Epithelial cells [#/volume] in Urine

1130

8140

1.50

29.33

3.5

2.6

e6/l

3.6

6.1

18.51

1008

7142

(36304419) Bacteria [Presence] in Urine

1396

10506

1.46

29.02

4.0

3.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4382

40796

1.72

28.62

17.2

13.2

mg/l

22.4

22.8

0.38

3491

32082

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2014

16255

1.41

28.25

2.6

2.2

nmol/l

78.6

76.0

4.28

1860

14821

(3044889) 12 lead EKG panel

3114

27201

1.40

26.56

4.1

3.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4069

37399

1.53

25.87

5.4

4.7

mu/l

1.8

2.1

1.54

3838

34613

(3026782) Osmolality of Urine

1038

7523

1.48

25.66

3.9

2.8

mosm/kgh2o

512.4

550.7

0.44

899

6399

(3035941) MCH [Entitic mass]

4754

45656

2.53

25.62

25.3

19.2

30.2

0.75

4718

45080

(3024731) MCV [Entitic volume]

4754

45658

2.53

25.58

25.4

19.2

90.7

0.44

4718

45086

(3014576) Chloride [Moles/volume] in Serum or Plasma

691

4591

1.59

25.53

7.3

6.9

mmol/l

104.6

104.5

0.16

685

4487

(3007461) Platelets [#/volume] in Blood

4752

45635

2.51

25.49

25.5

19.3

e9/l

252.2

253.8

0.90

4675

44573

(3026361) Erythrocytes [#/volume] in Blood

4754

45664

2.52

25.46

25.5

19.3

e12/l

4.5

0.54

4664

44509

(3010813) Leukocytes [#/volume] in Blood

4755

45678

2.53

25.46

25.5

19.3

e9/l

6.6

6.7

2.72

4664

44506

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1691

13416

1.40

25.46

4.2

3.2

u/l

29.7

35.1

2.76

1617

12778

(40761511) CBC panel - Blood by Automated count

4526

42730

1.80

25.38

15.2

12.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

875

6140

1.52

25.27

5.4

3.4

mmol/l

0.8

0.21

823

5752

(3037467) Urinalysis macro (dipstick) panel - Urine

3170

27879

1.39

25.23

5.3

4.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

4754

45677

2.51

25.21

25.6

19.4

g/l

134.9

135.6

3.41

4717

45099

(40758558) Short blood count panel - Blood

1323

10098

1.43

24.72

9.6

6.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1610

12733

1.39

24.45

4.7

3.2

mmol/l

2.3

2.4

0.26

1441

11230

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4561

43241

1.82

24.06

13.1

9.8

u/l

25.6

26.4

1.36

4451

41814

(3023103) Potassium [Moles/volume] in Serum or Plasma

4382

41146

1.63

23.32

19.6

14.8

mmol/l

3.9

4.0

1.93

4309

40012

(3019550) Sodium [Moles/volume] in Serum or Plasma

4371

41021

1.62

23.27

19.3

14.7

mmol/l

139.7

139.6

0.82

4301

39979

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

918

6648

1.47

22.42

3.6

2.9

mmol/l

2.4

0.63

817

5794

(3031040) Bacteria [#/volume] in Urine by Automated count

3012

26506

1.36

22.35

4.9

4.2

e6/l

139.3

1525.4

3.62

340

(3000991) Gas panel - Venous blood

487

3064

1.65

22.32

9.9

8.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

5.41

22.10

1.0

2.1

ug/l

1.5

1.9

0.54

(3017143) Hepatitis C virus Ab [Presence] in Serum

760

5326

1.51

21.80

2.1

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

968

7146

1.44

21.24

4.1

3.5

ng/l

355.7

597.7

0.77

719

5214

(3003338) MCHC [Mass/volume]

3852

35391

1.42

21.09

22.4

16.6

g/l

332.6

332.7

0.40

3837

35138

(3021447) Carbon dioxide [Partial pressure] in Venous blood

520

3372

1.61

21.06

5.8

3.7

kpa

5.9

5.8

0.06

502

3268

(3004789) Transferrin [Mass/volume] in Serum or Plasma

784

5567

1.49

21.02

3.8

2.4

g/l

2.3

2.4

3.13

742

5167

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3499

31653

1.37

20.90

4.5

4.0

pmol/l

14.7

14.6

0.41

3253

29053

(3002032) Base excess in Venous blood by calculation

517

3358

1.60

20.79

5.9

3.8

mmol/l

1.3

1.9

3.30

425

2695

(40760892) CBC W Ordered Manual Differential panel - Blood

1210

9335

1.39

20.59

5.7

4.4

—

(3042733) HLA Ab [Presence] in Serum

127

4.21

20.20

5.4

4.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

240

1273

1.93

19.64

2.0

1.7

g/l

1.2

0.81

232

1201

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

311

1797

1.78

19.40

6.5

3.9

mmol/l

23.6

24.1

2.03

284

1614

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2202

18743

1.32

19.25

3.5

2.9

ug/l

113.6

111.9

0.15

2082

17498

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

727

5169

1.48

19.23

3.9

2.5

23.3

0.00

640

4455

(3007853) Bacteria identified in Skin by Aerobe culture

673

4712

1.50

19.21

2.1

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

828

6045

1.45

19.07

3.7

2.4

umol/l

13.3

13.5

0.33

790

5630

(3013826) Glucose [Moles/volume] in Serum or Plasma

2626

22944

1.31

18.81

5.9

4.6

mmol/l

6.6

0.41

2464

21287

(3021879) Hepatitis B virus core Ab [Presence] in Serum

518

3465

1.55

18.26

1.6

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

117

481

2.47

18.21

1.7

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

2297

19767

1.31

18.12

5.8

4.7

estimate

0.0

0.80

414

3853

(3009261) Glucose [Presence] in Urine by Test strip

2316

19975

1.30

17.87

4.3

3.5

estimate

0.0

1.57

398

3727

(40768446) Kidney Pathology biopsy report

153

3.69

17.86

2.2

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3173

28566

1.32

17.72

3.4

3.2

—

(3032080) INR in Blood by Coagulation assay

1789

14927

1.31

17.54

9.4

8.6

inr

1.2

0.45

486

4430

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1827

15300

1.31

17.40

2.0

1.9

pmol/l

95.2

96.0

0.34

978

8142

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

284

1667

1.75

16.78

1.9

1.8

g/l

1.4

1.5

0.79

249

1445

(3035350) Ketones [Presence] in Urine by Test strip

2279

19740

1.29

16.52

4.3

3.4

estimate

0.0

1.08

401

3738

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

538

3706

1.51

16.50

2.8

2.4

u/l

35.6

50.6

0.59

471

3181

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

993

7654

1.37

16.46

1.9

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4264

40314

1.45

16.41

5.2

4.5

mmol/l

2.7

2.8

4.30

4022

37513

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

162

799

2.06

16.33

1.8

1.4

u/ml

117.3

110.8

0.39

162

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1387

11258

1.32

16.28

2.4

2.1

u/l

171.0

218.8

1.67

1307

10627

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2217

19174

1.29

16.11

4.2

4.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

881

2.00

15.97

1.9

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

630

4511

1.46

15.88

3.9

2.7

umol/l

6.1

7.8

3.38

555

3904

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4206

39713

1.42

15.85

4.7

4.1

mmol/l

4.6

4.7

4.48

3998

37186

(3000494) Fungus identified in Specimen by Culture

656

4744

1.44

15.67

1.6

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

10.66

15.54

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1167

9298

1.34

15.45

2.3

1.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

417

2759

1.56

15.37

4.5

3.0

kpa

4.8

4.6

1.22

399

2665

(3030981) Hyaline casts [#/volume] in Urine by Automated count

314

1943

1.66

15.27

4.1

2.8

e6/l

0.2

0.3

0.06

305

1891

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4177

39459

1.40

15.07

4.6

4.1

mmol/l

1.5

1.15

3940

36761

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

168

868

1.97

14.91

1.6

1.2

u/ml

296.4

261.0

0.65

110

545

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

265

1579

1.72

14.85

1.4

1.3

miu/ml

259.3

224.8

0.74

138

756

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4032

37922

1.36

14.51

15.9

12.0

ml/min/173m2

82.3

84.7

9.03

3364

31155

(3026493) Urate [Moles/volume] in Serum or Plasma

1254

10183

1.31

14.34

3.7

2.5

umol/l

4876.9

4351.0

0.16

1141

8922

(3018677) aPTT in Platelet poor plasma by Coagulation assay

771

5836

1.38

14.08

2.9

2.1

29.8

29.7

0.07

753

5655

(3042936) Bacteria identified in Isolate by Culture

731

5490

1.39

13.99

2.3

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

1525

12746

1.29

13.93

2.6

2.3

—

(3026008) Bacteria identified in Urine by Culture

1372

11319

1.29

13.85

3.2

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

250

1495

1.71

13.84

1.6

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

173

927

1.90

13.81

1.6

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1472

12265

1.29

13.73

3.4

2.5

u/l

57.7

57.6

0.01

1359

11347

(3011397) Hemoglobin [Presence] in Urine by Test strip

1140

9190

1.31

13.63

4.0

3.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4088

38643

1.35

13.33

4.8

4.2

mmol/l

5.8

5.9

1.50

3833

35565

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4035

38072

1.34

13.28

4.2

3.7

mmol/l

1.2

1.3

4.84

3790

35278

(3014111) Lactate [Moles/volume] in Serum or Plasma

463

3235

1.48

13.15

7.5

7.0

mmol/l

1.3

1.4

0.65

450

3113

(3009214) Lutropin [Units/volume] in Serum or Plasma

226

1334

1.73

13.13

1.4

u/l

11.0

9.9

0.51

185

1095

(3036481) Cortisol [Moles/volume] in Serum or Plasma

529

3799

1.44

13.02

3.6

2.1

nmol/l

368.5

373.2

0.23

493

3492

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

11.85

12.63

3.2

3.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.40

12.54

4.3

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

203

1182

1.75

12.39

3.1

3.3

u/ml

0.3

0.63

110

673

(3003396) Base excess in Arterial blood by calculation

565

4143

1.41

12.36

7.1

7.6

mmol/l

0.8

1.0

0.41

449

3215

(3004119) Hemoglobin [Mass/volume] in Venous blood

331

2189

1.55

12.21

3.8

3.1

g/l

126.3

129.5

1.78

322

2128

(3005719) IgG [Mass/volume] in Serum or Plasma

438

3075

1.47

12.13

2.9

2.7

g/l

10.6

10.5

0.06

412

2816

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

559

4107

1.41

12.09

1.8

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

4025

38086

1.32

12.06

19.0

13.9

39.8

39.9

0.40

3038

28643

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

556

4083

1.41

12.05

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

419

2933

1.47

11.78

2.4

2.1

nmol/l

11.9

12.3

0.37

377

2581

(3002173) Hemoglobin [Mass/volume] in Arterial blood

479

3444

1.43

11.68

7.8

8.4

g/l

119.3

122.4

2.63

462

3312

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

561

4160

1.39

11.47

7.2

7.6

kpa

5.1

0.02

540

3969

(3027801) Oxygen [Partial pressure] in Arterial blood

561

4160

1.39

11.47

7.2

7.6

kpa

13.0

12.5

1.44

539

3966

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

301

1978

1.56

11.43

8.7

10.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1101

9020

1.28

11.36

2.0

1.8

mg/l

1.1

0.04

813

6792

(42529406) Shigella sp [Presence] in Stool by Culture

202

1208

1.70

11.23

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.93

11.06

3.0

2.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1228

10252

1.26

10.77

1.7

1.6

mmol/l

1.4

0.30

1071

8717

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

383

2683

1.46

10.72

1.6

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

215

1325

1.65

10.68

2.8

2.2

94.0

92.3

0.49

202

1234

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

198

1196

1.68

10.62

3.4

2.4

188.3

182.6

0.37

188

1139

(3027945) Reticulocytes/100 erythrocytes in Blood

552

4134

1.38

10.61

3.4

2.6

1.7

1.8

1.80

506

3667

(3024928) Oxygen saturation in Venous blood

144

795

1.84

10.56

3.4

2.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

198

1200

1.68

10.50

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1173

9771

1.26

10.44

3.1

3.0

ng/l

1458.4

1294.0

0.56

1024

8307

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

1189

1.68

10.36

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1194

9988

1.26

10.21

2.4

2.2

mg/l

2.7

2.9

1.24

1044

8558

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

914

7401

1.29

10.21

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1132

9425

1.26

10.06

4.7

4.2

22.8

21.8

1.61

572

4553

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

203

1254

1.65

10.01

3.0

2.3

ug/l

450.7

655.0

0.46

189

1169

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

104

525

2.00

9.99

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

285

1908

1.52

9.97

9.2

9.7

mmol/l

24.3

24.2

0.17

272

1793

(3016502) Oxygen saturation in Arterial blood

499

3718

1.38

9.88

7.6

8.0

96.3

95.8

1.16

481

3576

(3023368) Bacteria identified in Blood by Culture

1193

10019

1.25

9.80

4.7

4.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

332

2303

1.47

9.78

8.6

7.2

mmol/l

24.3

24.8

1.78

332

2291

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

108

558

1.96

9.72

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

844

6805

1.29

9.70

3.4

3.0

ug/l

0.8

0.02

604

4509

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3814

36097

1.26

9.69

6.1

5.3

mmol/mol

38.9

39.2

1.54

3604

33654

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

198

1233

1.63

9.48

2.1

1.7

g/l

0.2

0.61

190

1163

(3021960) Folate [Moles/volume] in Serum or Plasma

1035

8600

1.26

9.26

1.6

1.5

nmol/l

22.1

20.5

1.79

919

7443

(3022145) Colonoscopy Study observation

566

4354

1.34

9.11

1.4

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

331

2335

1.45

8.95

1.5

1.3

iu/l

24.9

27.3

0.68

291

1994

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

427

3153

1.39

8.92

3.1

2.6

ml/min/173m2

61.5

68.9

2.72

184

1221

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

294

2.26

8.78

2.4

e6/l

869.9

759.5

0.47

126

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

244

1629

1.52

8.68

3.2

2.6

0.7

0.13

234

1558

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

368

2663

1.41

8.65

3.8

3.3

pmol/l

4.4

4.5

2.02

347

2383

(3036489) Thrombin time

234

1550

1.54

8.63

2.7

2.0

21.3

0.00

203

1333

(3020630) Protein [Mass/volume] in Serum or Plasma

399

2930

1.39

8.62

2.7

2.5

g/l

66.5

66.6

0.15

372

2702

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.39

8.60

14.7

11.5

mmol/l

5.5

5.9

0.25

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.05

8.51

3.2

3.1

—

22.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

371

2697

1.41

8.50

1.3

u/ml

166.2

204.2

0.35

352

2494

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1029

8626

1.24

8.42

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

148

883

1.70

8.39

4.7

4.0

—

(3048689) Calprotectin [Mass/mass] in Stool

662

5271

1.30

8.30

2.6

2.4

ug/g

116.7

125.1

0.26

516

4190

(40768793) Breast Pathology biopsy report

144

859

1.70

8.18

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1359

11758

1.22

8.18

5.5

4.9

ug/l

3.0

2.9

0.09

1238

10552

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1140

9708

1.23

8.00

2.5

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

281

2.22

7.95

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

741

6021

1.27

7.90

1.9

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

155

953

1.65

7.87

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

191

1240

1.56

7.75

3.4

2.5

g/l

3.6

0.29

180

1174

(40768797) Stomach Pathology biopsy report

677

5463

1.28

7.62

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

180

1158

1.58

7.60

1.2

—

(3025941) Bacteria identified in Stool by Culture

330

2405

1.40

7.47

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

176

1134

1.57

7.39

3.3

3.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

329

2402

1.40

7.37

2.1

1.8

g/l

1.3

1.4

0.14

310

2203

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

231

1593

1.47

7.08

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

400

3035

1.35

7.06

3.2

2.6

e9/l

67.0

70.5

1.17

284

2291

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1350

1.51

7.01

2.1

2.3

g/l

3.7

3.8

0.53

146

989

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

473

3681

1.32

7.01

2.2

1.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

159

1014

1.59

7.00

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1351

1.51

6.99

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1351

1.51

6.99

2.1

2.3

g/l

7.2

7.4

0.95

147

1033

(3009508) Creatinine [Moles/volume] in Urine

1356

11875

1.20

6.98

4.1

3.2

mmol/l

7.4

7.8

1.95

1199

10096

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

469

3653

1.31

6.91

3.8

4.0

ug/l

5.0

24.1

4.93

361

2905

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2966

27740

1.18

6.88

3.4

3.0

u/l

41.4

45.5

2.83

2809

26080

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

112

656

1.72

6.86

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

234

2.24

6.84

3.5

2.7

39.4

40.5

—

(3024471) HLA-A [Type]

126

2.71

6.75

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

112

660

1.71

6.72

1.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1712

15342

1.18

6.69

4.5

3.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

183

1219

1.52

6.66

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

257

2.15

6.61

8.2

6.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

515

1.80

6.60

1.7

1.6

—

(44806118)

461

1.84

6.43

1.8

1.4

—

(44790047)

461

1.84

6.43

1.8

1.4

—

(44790048)

461

1.84

6.43

1.8

1.4

—

(44790049)

461

1.84

6.43

1.8

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

617

1.72

6.39

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

281

2.08

6.37

2.0

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

238

1688

1.43

6.33

5.0

3.4

mmol/l

24.8

25.2

1.12

227

1629

(3011985) Renin [Units/volume] in Plasma

493

1.80

6.31

1.5

mu/l

26.8

50.7

2.68

440

(3024932) HLA-DR beta [Type]

125

2.65

6.30

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1253

1.50

6.24

2.1

2.3

g/l

9.9

10.2

0.50

162

1084

(3002179) Metamyelocytes/100 leukocytes in Blood

396

3057

1.32

6.23

4.4

4.0

0.4

0.6

0.47

674

(3019150) Specific gravity of Urine by Refractometry

1001

8607

1.21

6.19

4.6

3.8

kg/l

1.0

1.05

118

1295

(3020682) Albumin/Creatinine [Ratio] in Urine

1281

11265

1.19

6.16

5.1

4.0

mg/mmol

11.9

9.8

0.64

875

7248

(40768795) Lymph node Pathology biopsy report

354

1.93

6.14

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

410

3188

1.31

6.12

5.1

4.2

0.1

0.2

0.58

121

852

(3037522) Nuclear Ab [Titer] in Serum

681

5638

1.24

6.11

1.4

titre

385.4

538.3

2.16

134

1145

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

379

2916

1.32

6.10

3.4

2.9

ng/l

182.8

182.0

0.02

349

2632

(3017181) Myelocytes/100 leukocytes in Blood

427

3341

1.30

6.09

5.0

4.2

0.9

0.03

127

919

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

347

2637

1.34

6.08

1.3

au/ml

66.7

45.7

—

111

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

374

2875

1.33

6.06

2.4

au/ml

29.7

24.0

0.36

184

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

130

821

1.60

6.02

4.0

3.7

55.5

57.4

0.95

130

821

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

209

1463

1.45

5.98

4.4

5.6

1.7

0.09

196

1364

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

347

1.91

5.81

3.3

3.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

376

2911

1.32

5.80

2.1

1.8

—

(3012516) Albumin [Mass/volume] in Urine

1220

10732

1.18

5.79

4.2

3.3

mg/l

426.8

325.7

0.32

826

6862

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

413

1.83

5.73

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

707

1.63

5.70

6.4

3.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

183

1261

1.47

5.70

3.3

3.5

u/ml

200.9

4010.2

1.03

153

1073

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1092

9527

1.19

5.70

1.3

u/ml

1.2

1.7

0.98

301

2573

(3004809) Band form neutrophils/100 leukocytes in Blood

100

600

1.68

5.68

3.1

3.3

1.1

1.4

0.72

465

(40761535) Cells panel - Urine sediment

396

3099

1.30

5.65

5.0

3.3

—

(3025130) Human papilloma virus identified in Specimen

104

634

1.65

5.57

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

462

1.77

5.52

1.3

1.4

pmol/l

331.6

283.5

0.90

359

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

405

1.81

5.46

6.7

4.6

u/ml

212.4

71.8

0.39

117

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

121

770

1.59

5.46

2.1

1.5

—

(3025159) Blasts/100 leukocytes in Blood

385

3017

1.30

5.45

5.2

4.3

0.0

0.3

1.10

715

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

451

3609

1.28

5.42

2.7

2.3

g/l

0.2

2.51

428

3375

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1267

1.45

5.40

2.2

2.3

g/l

2.9

3.1

2.08

146

1012

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

140

924

1.53

5.39

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

963

8348

1.19

5.38

1.6

1.4

g/l

2.3

0.33

608

5216

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

153

1030

1.50

5.37

2.1

2.2

g/l

0.0

0.63

144

960

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

455

1.75

5.23

1.1

—

47.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

137

907

1.53

5.21

1.6

—

(3049717) Cytology report of Urine Cyto stain

194

1377

1.43

5.20

2.4

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

202

1446

1.41

5.16

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

312

2394

1.32

5.16

2.2

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

203

1458

1.41

5.10

4.4

5.7

0.9

0.12

192

1360

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

119

768

1.56

5.08

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

119

768

1.56

5.08

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

152

2.31

5.08

3.7

1.9

142.8

160.6

0.58

141

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.27

5.04

5.4

4.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

199

1434

1.40

4.92

1.6

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

257

1933

1.35

4.88

2.5

2.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1161

1.44

4.84

2.4

g/l

0.6

0.9

0.80

146

1024

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

476

3887

1.25

4.83

3.0

3.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

156

2.25

4.81

1.6

1.5

73.4

73.7

0.04

151

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

150

2.28

4.78

1.6

1.5

mu/l

2972.1

416.4

0.46

145

(3013139) Helicobacter pylori Ag [Presence] in Stool

342

2687

1.29

4.77

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

247

1854

1.35

4.76

1.8

1.6

mu/l

301.2

294.0

0.17

231

1663

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

470

1.69

4.70

1.1

—

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

418

1.73

4.68

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

816

1.52

4.68

1.8

1.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.02

4.57

5.7

4.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

139

951

1.48

4.56

2.1

2.3

g/l

0.0

0.00

131

895

(3029937) Albumin [Presence] in Urine by Test strip

1190

10630

1.16

4.51

4.9

3.8

estimate

0.0

0.46

398

3712

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

140

962

1.47

4.50

2.1

2.2

g/l

0.0

0.50

131

896

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

364

1.77

4.48

1.2

1.1

mg/l

44.4

39.1

0.49

298

(3001964) Herpes simplex virus Ag [Presence] in Specimen

123

2.37

4.47

2.0

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

168

2.15

4.45

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

106

690

1.55

4.41

2.8

2.1

umol/l

6.6

5.8

0.25

496

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

352

1.77

4.38

1.1

mg/l

269.5

255.7

0.27

303

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

636

1.57

4.37

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

110

726

1.53

4.31

1.2

1.3

ug/l

3.4

3.9

0.52

670

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

311

1.81

4.26

1.2

1.3

titre

256.3

184.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

311

1.81

4.26

1.2

1.3

titre

275.0

53.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

150

1057

1.43

4.25

2.1

2.2

g/l

38.3

37.9

0.51

137

930

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

371

2998

1.26

4.15

2.6

2.3

ug/l

11.7

7.5

1.00

337

2668

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.01

4.06

2.8

4.2

—

(3051611) Lipemic interference index of Serum or Plasma

361

1.73

4.04

3.8

3.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

214

1621

1.33

3.94

1.9

1.6

u/ml

7.6

16.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

1320

1.37

3.92

1.7

1.6

iu/ml

17.5

5.9

0.28

267

(3036603) Volume of Urine

247

1.87

3.92

1.6

1.5

2088.0

2017.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

107

719

1.50

3.89

1.4

u/l

22.0

25.0

0.47

602

(4027681)

278

1.81

3.83

1.4

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

577

1.55

3.82

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

160

2.07

3.75

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

146

1050

1.40

3.74

2.8

3.5

mg/l

32.1

65.3

1.64

117

852

(4034850)

1286

0.65

3.71

11.7

9.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

146

1053

1.40

3.68

1.2

1.3

mg/l

506.7

513.0

0.05

134

995

(3016038) Potassium [Moles/volume] in Urine

224

1.88

3.67

1.1

1.2

mmol/l

29.3

34.4

0.67

197

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

1055

1.40

3.64

1.8

2.0

mg/l

10.4

10.9

0.41

137

979

(3003694) ABO and Rh group [Type] in Blood

1341

12238

1.13

3.60

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

205

1567

1.32

3.58

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

220

1699

1.31

3.57

1.7

1.9

u/l

38.1

38.9

0.26

193

1528

(3034860) Kappa light chains.free [Mass/volume] in Serum

145

1051

1.39

3.56

2.8

3.5

mg/l

66.7

57.4

0.31

115

850

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

337

1.70

3.56

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

437

1.61

3.55

1.6

—

(3037121) Protein [Mass/volume] in Urine

176

1317

1.35

3.55

5.2

3.0

g/l

0.3

0.16

109

551

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

759

1.46

3.54

1.4

1.5

nmol/l

0.4

0.03

608

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

390

4682

0.82

3.54

4.7

4.2

33.1

32.1

1.10

284

3239

(40768441) Liver Pathology biopsy report

293

1.75

3.53

1.7

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

158

1165

1.37

3.51

2.9

2.7

—

(3047181) Lactate [Moles/volume] in Blood

160

1183

1.36

3.49

4.9

6.6

mmol/l

1.1

1.3

1.41

135

1034

(3019832) Treponema pallidum Ab [Presence] in Serum

621

5376

1.18

3.48

1.9

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

409

1.62

3.46

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

2.13

3.44

3.2

1.9

u/ml

350.0

27949.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

283

2274

1.26

3.38

6.6

7.2

mmol/l

24.7

24.5

0.33

267

2114

(3016650) Hepatitis A virus Ab [Presence] in Serum

102

702

1.46

3.35

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

127

2.13

3.35

2.4

1.5

—

(3011648) Oxygen content in Venous blood

298

1.72

3.34

2.8

2.2

11.2

11.1

0.06

298

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.25

3.34

2.2

2.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

129

928

1.40

3.34

1.2

mmol/l

3.7

0.25

116

866

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

492

1.55

3.33

5.9

6.7

mg/l

10.7

11.6

1.00

463

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.72

3.32

2.1

1.6

ng/l

106.7

136.7

0.50

(3041096) Erythrocytes [Presence] in Urine by Automated

1205

10986

1.13

3.25

4.0

3.1

—

(3051651) Icteric interference index of Serum or Plasma

227

1.81

3.23

4.5

3.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

274

2207

1.26

3.22

2.3

2.2

u/l

3966.1

5825.9

0.51

120

887

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

206

1.85

3.20

1.2

1.1

u/l

32.0

22.8

0.33

176

(1617658) Protocol used for examination of sentinel lymph nodes

287

1.71

3.20

1.0

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

123

885

1.40

3.19

5.6

3.2

kpa

8.9

8.3

3.17

113

820

(21494890) Protein electrophoresis panel - 24 hour Urine

356

1.64

3.19

1.4

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

706

1.44

3.09

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

286

2329

1.24

3.06

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

202

1.84

3.06

1.2

1.1

miu/ml

1665.0

1452.6

0.53

202

(3042111) Morphology [Interpretation] in Bone marrow Narrative

600

1.48

3.06

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

195

1.85

3.05

1.4

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

400

1.58

3.04

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

119

860

1.39

3.03

1.2

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

138

1022

1.36

3.03

2.8

3.5

ratio

1.1

2.1

—

(3000330) Specific gravity of Urine by Test strip

236

1885

1.26

3.00

4.8

3.3

—

(21494755) Public health laboratory ask at order entry panel

380

4497

0.83

2.99

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

169

1.90

2.94

1.3

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

530

4597

1.17

2.92

8.2

6.4

—

(3019060) Gas panel - Arterial blood

290

2381

1.23

2.90

4.5

5.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

616

1.45

2.89

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

153

1161

1.33

2.88

1.7

nmol/l

42.2

41.6

0.10

153

1124

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.59

2.87

3.2

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

367

1.59

2.86

1.2

1.1

u/l

88.8

61.4

0.49

252

(3015171) Extractable nuclear Ab [Units/volume] in Serum

207

1638

1.28

2.85

1.3

1.2

u/ml

1.6

1.0

0.18

139

(3045414) Leukocytes [Presence] in Urine

228

1827

1.26

2.84

1.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.45

2.79

3.4

2.9

—

(3023410) Appearance of Cerebral spinal fluid

409

1.55

2.79

1.3

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.65

2.79

1.1

1.3

—

(4010399)

328

2739

1.21

2.79

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

365

3080

1.20

2.78

1.2

iu/ml

133.7

158.5

0.52

123

1154

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

269

1.68

2.77

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

918

1.36

2.76

1.3

1.4

e6/l

730.5

1282.5

0.35

756

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

124

918

1.36

2.76

1.2

1.4

e6/l

6.5

28.0

2.34

717

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

217

1.76

2.75

1.2

1.1

u/l

83.4

86.8

0.09

189

(3032773) Endomysium IgG Ab [Titer] in Serum

363

1.58

2.74

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

302

1.63

2.70

2.4

2.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1507

14038

1.11

2.70

3.5

3.4

ng/l

81.4

54.2

0.27

937

8903

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

676

1.41

2.68

1.6

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.21

2.63

1.2

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

1.82

2.63

1.2

—

(3000492) Spirometry study

460

3987

1.17

2.58

1.6

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.90

2.58

7.2

3.4

g/mol

29.3

33.8

0.08

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

641

1.41

2.55

1.2

1.1

112.7

116.0

0.42

578

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

1.80

2.55

4.8

3.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

193

1.77

2.53

1.2

1.3

—

(3016750) Collection duration of Urine

231

1.69

2.51

3.1

2.2

min

502.9

488.2

0.41

170

(3045788) Cell count panel - Pleural fluid

324

1.58

2.51

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

518

1.45

2.51

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

360

3066

1.19

2.50

6.0

3.7

mmol/l

1.2

0.15

316

2677

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

495

1.46

2.47

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

302

1.60

2.46

3.0

2.3

760.5

616.8

1.42

204

(3036525) Urea [Moles/time] in 24 hour Urine

3.81

2.46

2.3

3.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

123

1.96

2.44

1.5

1.4

ug/l

7.9

8.3

0.43

123

(3003434) Protein [Mass/volume] in Pleural fluid

439

1.49

2.44

1.5

g/l

33.8

32.7

0.25

395

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.55

2.44

1.1

—

(3045142) Bone marrow Pathology biopsy report

407

1.51

2.43

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

304

1.58

2.40

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

117

1.97

2.40

2.4

1.8

e6/l

80.0

176.7

2.55

(43055514) Macroprolactin [Presence] in Serum or Plasma

124

1.94

2.40

1.5

1.4

—

(40768806) Pleura Pathology biopsy report

344

1.55

2.39

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

740

6671

1.13

2.38

1.7

nmol/l

1146.3

1166.5

0.23

587

5093

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.64

2.36

1.1

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

2.35

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

198

1.72

2.35

1.2

1.3

—

(3013512) EKG study

1152

10657

1.11

2.33

3.9

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

519

4578

1.15

2.32

28.1

22.7

inr

1.3

0.18

684

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

557

4944

1.14

2.28

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

254

1.62

2.26

1.5

u/ml

18.7

21.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

406

1.48

2.26

1.5

1.4

e6/l

1021.8

2336.4

2.24

291

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.02

2.25

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

439

1.46

2.25

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

144

1128

1.28

2.23

1.4

1.2

titre

45.5

117.3

1.98

(1002224) Polysomnography panel

210

1720

1.23

2.22

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

400

1.48

2.20

2.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

626

1.38

2.19

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

140

1100

1.28

2.13

1.4

ug/g

276.9

285.6

0.19

620

(3039000) Anion gap in Blood

109

828

1.32

2.12

6.1

7.7

mmol/l

11.2

11.3

0.10

736

(3024980) IgG subclass 4 [Mass/volume] in Serum

673

1.36

2.12

1.5

1.7

g/l

0.5

0.8

2.12

516

(3028433) Virus identified in Specimen by Culture

130

1.85

2.12

1.3

1.2

—

(3018572) Chloride [Moles/volume] in Blood

109

829

1.32

2.11

6.1

7.7

mmol/l

105.3

105.4

0.12

737

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.71

2.10

1.5

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

573

1.38

2.08

1.2

—

(3021901) Oxygen saturation in Capillary blood

693

1.35

2.07

4.3

2.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

104

791

1.32

2.02

2.7

3.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

286

1.54

2.02

1.1

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

177

1.70

2.01

1.8

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

177

1.70

2.01

1.8

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.08

2.01

1.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

345

1.48

1.96

1.2

1.1

—

(3025315) Body weight

2.97

1.93

7.3

3.6

—

(3011412) CD3 cells [#/volume] in Blood

404

1.44

1.93

2.2

2.3

e9/l

1.1

1.2

0.36

228

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

133

1054

1.27

1.92

1.8

1.9

iu/l

4.5

4.7

0.09

396

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

275

2348

1.18

1.92

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

290

1.52

1.92

2.2

2.3

e6/l

505.3

538.5

0.18

235

(3020891) Body temperature

176

1442

1.23

1.90

5.1

4.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

307

1.50

1.89

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

704

1.33

1.89

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.18

1.88

1.1

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

212

1.61

1.88

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

578

0.65

1.87

3.9

5.4

umol/l

369.0

365.4

0.04

501

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

1.85

1.86

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

284

1.52

1.86

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

341

1.47

1.86

1.7

1.3

titre

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

138

1105

1.26

1.84

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

122

1.81

1.83

1.3

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

253

1.55

1.83

1.1

nmol/l

0.6

6.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

120

1512

0.79

1.83

1.5

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

990

1.27

1.83

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

101

1.88

1.80

10.4

7.3

—

(3047189) Immunofixation for 24 hour Urine

168

1.67

1.80

1.3

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

109

851

1.29

1.79

1.2

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.76

1.79

1.0

1.3

—

(3003181) Sodium [Moles/volume] in Urine

590

1.34

1.78

1.2

1.4

mmol/l

74.5

62.8

1.72

476

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

677

1.32

1.77

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

362

1.44

1.76

1.5

1.4

e6/l

78513.5

90545.8

0.06

218

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.87

1.76

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.90

1.75

1.3

1.1

pmol/l

251.8

265.3

0.11

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

139

1122

1.25

1.74

1.8

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.94

1.74

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

1.80

1.74

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

1.80

1.74

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

431

1.40

1.72

1.1

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.92

1.72

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

105

1332

0.78

1.71

2.1

3.1

—

(1616796) Gas panel - Central venous blood

111

876

1.27

1.69

5.3

3.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

1.75

1.67

2.7

2.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

519

1.35

1.67

1.3

u/ml

65.1

44.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

258

2223

1.17

1.65

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

309

1.46

1.65

2.1

2.0

13.6

13.5

0.02

144

(40765096) Chromosome analysis panel by Banding

112

1.79

1.64

1.2

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

181

1.61

1.63

2.2

1.9

umol/l

2.1

1.9

0.41

169

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.57

1.61

8.0

5.6

umol/l

333.8

407.8

—

(3037756) Immunofixation for Serum or Plasma

697

1.30

1.60

1.4

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

120

965

1.25

1.58

4.6

3.3

mmol/l

23.7

24.9

2.13

105

847

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

1.74

1.58

1.3

1.1

—

(3012441) Differential panel - Pleural fluid

346

1.42

1.57

1.4

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

101

798

1.27

1.55

1.7

1.9

pmol/l

184.5

198.3

0.62

748

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

137

1.68

1.55

1.0

1.1

83.5

91.3

0.53

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

879

1.26

1.54

1.3

1.2

u/ml

53.9

41.9

0.32

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

145

1.66

1.53

1.3

1.2

111.1

108.3

0.25

127

(40761539) Cells [Type] in Urine sediment by Light microscopy

100

1.80

1.52

1.4

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.70

1.52

1.0

1.2

85.9

90.8

0.23

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

257

1.48

1.52

1.2

1.1

iu/ml

12.1

10.6

0.09

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.86

1.50

1.2

1.1

—

(4281824)

392

0.64

1.47

1.1

—

(3045424) Erythrocytes [Presence] in Urine

689

1.28

1.47

1.5

—

(3005033) Fetal Nuchal fold Thickness US

147

1222

1.21

1.45

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

148

1.62

1.44

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

111

899

1.24

1.41

3.1

2.5

ug/min

162.8

98.9

0.74

560

(3008757) Leukocyte morphology finding [Identifier] in Blood

388

1.37

1.41

3.4

3.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

147

1226

1.21

1.41

1.3

1.4

—

(4024509)

374

0.64

1.39

1.3

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.00

1.38

1.3

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

247

1.46

1.37

1.3

1.6

u/l

5.9

6.9

0.53

217

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.61

1.36

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.94

1.36

1.0

1.1

7.2

8.5

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.94

1.36

1.0

1.1

20.8

21.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.94

1.36

1.0

1.1

37.6

36.4

—

(4062490)

426

1.34

1.3

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.76

1.34

6.2

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.76

1.34

3.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.14

1.33

2.4

2.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

282

1.42

1.33

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

489

5346

0.91

1.32

1.8

1.7

1.4

0.77

446

4744

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

258

1.44

1.31

1.1

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

131

1091

1.21

1.29

4.2

mmol/l

3.9

0.26

125

1020

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

1.46

1.28

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

324

2897

1.13

1.28

1.5

—

(40757373) Influenza virus identified in Isolate

1.79

1.27

2.6

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

302

1.39

1.27

1.4

1.3

nmol/l

27.2

32.7

0.68

273

(3012898) Urea [Moles/volume] in Urine

2.29

1.26

1.4

mmol/l

185.1

185.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.38

1.26

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.38

1.26

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

1260

1.19

1.26

1.4

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

320

1.38

1.25

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.40

1.24

1.5

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.22

1.24

1.4

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

195

1.49

1.24

11.1

6.6

u/ml

52.4

176.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

852

1.23

1.22

2.7

2.3

g/l

130.1

0.00

624

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.77

1.22

1.1

1.2

—

(4306422)

663

1.26

1.22

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

717

1.25

1.22

1.2

—

(3017732) Neutrophils [#/volume] in Blood

317

2841

1.12

1.22

2.4

2.8

e9/l

4.3

4.1

0.44

259

2277

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

1.39

1.22

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.63

1.21

1.2

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.63

1.21

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

305

1.38

1.21

1.8

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

665

1.25

1.20

1.3

1.2

u/ml

5.1

4.5

0.13

282

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

683

1.25

1.20

1.3

1.2

u/ml

1.4

3.7

2.87

227

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

148

1.56

1.19

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

148

1.56

1.19

1.2

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

383

1.34

1.19

1.3

1.4

mmol/l

10.9

12.3

0.49

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

167

1435

1.17

1.18

2.1

2.0

ug/l

3.4

2.2

0.34

150

1285

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

163

1399

1.17

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

350

1.35

1.17

3.1

2.5

—

(3044941) Cell count panel - Synovial fluid

605

1.26

1.17

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

1.67

1.16

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

240

1.42

1.15

1.4

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.50

1.15

7.8

10.1

e6/l

75.2

142.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.73

1.15

3.6

2.9

ng/l

91.9

146.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

317

1.36

1.14

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

317

1.36

1.14

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

174

1507

1.16

1.13

1.3

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

241

2136

1.13

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

318

1.36

1.12

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

174

1509

1.16

1.11

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

423

1.30

1.11

1.2

1.4

g/l

0.3

0.4

0.57

300

(3017354) Segmented neutrophils/100 leukocytes in Blood

362

1.33

1.11

2.2

3.1

63.4

57.4

0.91

233

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

174

1510

1.16

1.10

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

458

0.72

1.10

2.4

2.1

mg/l

26.6

22.0

—

119

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

285

1.37

1.10

1.2

—

(3016879) Cocaine [Presence] in Urine

154

1785

0.86

1.10

1.7

2.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

424

1.30

1.10

1.2

1.4

g/l

6.0

6.7

1.40

301

(3028192) IgG subclass 2 [Mass/volume] in Serum

424

1.30

1.10

1.2

1.4

g/l

3.0

2.9

0.09

302

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

337

1.34

1.09

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

337

1.34

1.09

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

337

1.34

1.09

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

372

1.32

1.09

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.95

1.08

1.5

1.1

—

(3019225) pH of Specimen

338

3722

0.90

1.08

7.0

4.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

173

1504

1.16

1.08

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.69

1.07

12.6

7.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

371

4061

0.91

1.06

1.6

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

287

1.36

1.06

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.92

1.06

1.4

1.3

—

(3012501) Base excess in Blood by calculation

105

877

1.20

1.06

5.2

4.2

mmol/l

2.4

2.5

0.11

586

(40767503) Oxygen content in Capillary blood by calculation

815

1.21

1.04

3.3

2.5

16.8

16.4

0.57

416

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

446

1.28

1.03

1.3

—

41.3

—

(3027944) Amphetamines [Presence] in Urine

167

1912

0.87

1.03

1.7

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

186

1633

1.14

1.02

1.3

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

196

1.43

1.02

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

196

1.43

1.02

1.3

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

196

1.43

1.02

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

1.43

1.02

1.3

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

213

1.41

1.01

2.1

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

790

1.21

1.01

4.8

2.0

nmol/l

0.8

0.64

667

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

308

1.33

0.99

1.9

1.3

u/ml

2.3

0.6

1.06

129

(3028300) Cannabinoids [Presence] in Urine

171

1949

0.87

0.99

1.7

2.2

—

(4268621)

449

1.27

0.99

2.4

2.3

—

(40761536) Microorganisms panel - Urine sediment

384

3525

1.10

0.98

4.8

3.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.81

0.98

2.9

1.4

—

(4038314)

2.18

0.98

1.0

1.2

—

(3014271) Vancomycin [Susceptibility]

160

0.56

0.97

2.3

2.7

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.97

0.0

1.3

—

2715.4

—

(3009871) Measles virus Ab [Titer] in Serum

140

1.50

0.97

1.6

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

170

1934

0.87

0.97

1.7

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.80

0.96

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

516

4804

1.08

0.96

1.5

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.74

0.96

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.74

0.96

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.74

0.96

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

171

1943

0.88

0.96

1.7

2.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

0.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.65

0.94

10.5

2.9

u/l

75.7

90.6

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

2.14

0.91

5.7

1.4

nmol/l

2.7

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.67

0.91

1.3

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

287

1.33

0.91

1.1

ratio

1.1

1.0

—

110

(3014051) Protein [Presence] in Urine by Test strip

939

0.83

0.91

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

296

1.32

0.90

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

746

1.20

0.90

1.7

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.00

0.87

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

128

1.49

0.85

1.9

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

614

1.21

0.84

1.2

1.4

—

(3024263) Appearance of Synovial fluid

205

1.37

0.83

2.4

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

0.53

0.83

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

1172

1.15

0.82

1.3

1.2

u/ml

45.5

40.2

0.10

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.65

0.81

3.2

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.70

0.80

1.1

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

177

1581

1.12

0.80

1.8

1.6

—

(3017704) Immunofixation for Urine

198

1.37

0.80

1.2

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

259

0.69

0.79

1.3

2.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

207

1.35

0.79

1.0

1.1

90.3

93.9

0.22

162

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.82

0.79

1.7

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

483

1.22

0.78

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

148

1.42

0.77

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

100

0.50

0.77

1.0

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

115

1.48

0.76

1.3

1.6

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.76

0.0

1.2

—

0.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.70

0.75

1.9

pmol/l

17.0

40.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

147

1304

1.13

0.75

2.3

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.00

0.72

1.6

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

488

1.21

0.72

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

895

1.15

0.72

1.6

e6/l

14414.7

11370.5

0.20

642

(3004616) Nuclear Ab [Presence] in Serum

501

0.80

0.72

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.67

0.72

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

353

1.25

0.71

3.8

3.2

mg/l

76.1

43.4

0.40

263

(3008295) Osmolality of Serum or Plasma

390

1.23

0.70

1.6

1.4

mosm/kgh2o

282.7

280.2

0.44

299

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

253

2751

0.92

0.70

1.4

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.71

0.70

1.7

1.4

77.2

75.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.68

1.6

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.60

0.68

1.3

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

492

1.20

0.68

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

136

1212

1.13

0.67

1.1

u/ml

2.2

4.6

1.02

171

(4146454)

385

0.78

0.67

3.3

2.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

595

1.18

0.66

3.3

3.1

nmol/l

0.8

0.21

455

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

162

1.36

0.66

1.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

476

1.20

0.65

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

277

1.27

0.65

1.1

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

504

1.19

0.65

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

166

0.66

0.64

2.3

2.5

—

(3004451) EKG impression Narrative

172

1.34

0.63

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

478

1.19

0.63

1.3

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

155

1.36

0.62

1.2

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

155

1.36

0.62

1.2

1.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

643

0.84

0.62

1.3

1.4

mmol/l

6.6

7.1

0.65

477

(3044927) Protein electrophoresis panel - Urine

342

1.23

0.62

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

333

1.23

0.62

1.1

1.3

mmol/l

2.1

0.14

310

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

178

1620

1.10

0.62

2.1

1.9

—

(3022621) pH of Urine by Test strip

242

2618

0.92

0.62

2.7

2.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.67

0.61

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

480

1.19

0.61

1.3

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3014891) Appearance of Pleural fluid

1.57

0.60

2.6

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

232

0.73

0.59

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

157

1.34

0.59

1.2

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

234

2527

0.92

0.58

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

852

0.87

0.58

2.1

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

585

1.16

0.58

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

283

1.24

0.56

1.8

2.3

—

(44813793)

293

1.23

0.55

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

206

1903

1.09

0.54

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.46

0.54

1.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

806

1.13

0.53

1.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

160

1.31

0.53

1.7

2.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

832

8031

1.04

0.53

1.6

pmol/l

34126319.1

32159081.2

0.03

715

6782

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.45

0.53

2.1

2.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.43

0.52

1.0

1.1

—

6.3

—

(3048879) Bone marrow aspiration report

0.62

0.52

1.5

2.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

126

1141

1.11

0.51

1.5

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

1469

0.91

0.49

6.8

3.6

mmol/l

24.5

24.8

0.95

122

1371

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.56

0.49

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.49

1.3

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

154

1.30

0.48

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.45

0.48

1.1

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

736

7110

1.04

0.46

1.3

iu/ml

25.1

29.5

0.53

215

2196

(3001556) Androgen free Index in Serum or Plasma

1.43

0.46

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

118

1074

1.10

0.45

1.3

1.2

u/ml

4.1

6.4

0.25

106

(3008536) Aspergillus sp Ab [Presence] in Serum

1.43

0.45

1.3

1.9

—

(4094501)

113

1027

1.10

0.45

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.40

0.45

6.7

2.1

pmol/l

87.7

79.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

737

0.88

0.44

2.9

3.5

u/ml

28.5

678.5

1.19

683

(21494434) Karyotype in Bone marrow

320

1.19

0.44

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

650

6273

1.04

0.44

2.5

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

119

1087

1.10

0.43

1.3

1.2

u/ml

2.7

7.7

1.91

172

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

858

1.11

0.43

1.3

1.2

u/ml

5.5

5.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.61

0.43

1.2

1.4

umol/24h

332.2

350.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

700

6771

1.04

0.42

1.3

u/ml

13.6

10.6

0.32

284

2700

(4198724)

207

0.77

0.42

1.9

2.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.56

0.42

1.2

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.38

0.42

1.9

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

140

1.29

0.41

1.2

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.38

0.41

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.52

0.41

1.2

1.8

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3020491) Glucose [Moles/volume] in Blood

323

1.18

0.41

1.7

1.8

mmol/l

6.5

0.05

229

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

445

0.85

0.41

1.6

mmol/l

6.7

7.6

1.86

275

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

596

1.13

0.40

1.2

u/l

23.7

45.2

1.53

515

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.40

0.0

1.3

—

4703.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.36

0.40

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

673

1.12

0.39

1.4

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.31

0.39

1.1

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.43

0.39

3.0

9.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

242

1.20

0.38

1.1

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

280

0.82

0.38

24.0

18.1

nmol/l

1349.9

1470.2

0.39

272

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3001729) Color of Synovial fluid

1.39

0.38

1.2

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

105

962

1.09

0.38

1.5

pmol/l

111.7

150.8

0.46

105

945

(3028679) Herpes simplex virus Ab [Presence] in Serum

252

1.19

0.37

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

280

1.18

0.37

1.2

1.6

—

(3010421) pH of Blood

113

1040

1.09

0.37

5.6

4.1

7.4

0.76

105

866

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

135

1454

0.93

0.37

2.3

1.8

—

(3020650) Glucose [Presence] in Urine

113

0.71

0.37

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.35

0.37

3.4

2.4

u/field

1.0

0.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.27

0.36

1.2

1.1

u/ml

0.2

3.5

—

(3035933) Granulocytes/100 leukocytes in Blood

135

0.74

0.36

1.0

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

726

1.10

0.35

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.43

0.35

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

451

1.13

0.35

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.40

0.35

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

461

1.13

0.34

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

292

1.17

0.34

1.3

1.4

pmol/l

54.7

169.4

0.55

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

276

0.83

0.34

20.2

12.9

nmol/l

883.3

843.2

0.17

263

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

255

1.18

0.34

1.2

1.1

u/l

1.0

1.1

1.02

123

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

633

1.11

0.34

1.1

1.0

u/ml

2.6

3.4

0.33

317

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

237

1.18

0.33

1.1

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

191

1.21

0.33

2.2

2.1

ug/min

166.8

160.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

266

1.17

0.32

1.9

1.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

341

1.14

0.32

1.3

1.1

—

27.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

229

1.18

0.32

1.6

u/l

14.3

5.9

0.28

117

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

560

0.89

0.32

1.0

1.1

u/ml

0.0

0.3

—

122

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.35

0.31

1.4

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

0.81

0.30

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

150

1594

0.94

0.30

2.3

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.30

1.6

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

1.20

0.30

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

292

0.86

0.29

1.2

1.1

u/ml

1.0

2.4

—

(1761868) Lipid panel - Serum or Plasma

1521

14985

1.02

0.29

3.1

2.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

130

1.23

0.28

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.32

0.28

1.4

2.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.6

1.2

—

(36660697) Celiac disease serology panel - Serum

358

3457

1.04

0.27

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

237

0.84

0.27

1.0

ng/l

34.5

45.9

1.04

149

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.27

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

579

5640

1.03

0.27

2.4

2.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

258

0.85

0.27

1.1

u/ml

0.3

2.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

131

1.22

0.27

1.8

2.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

248

2379

1.04

0.26

6.0

3.5

kpa

5.0

5.2

3.04

228

2220

(3009343) pH of Capillary blood

245

2350

1.04

0.26

5.9

3.5

7.4

0.00

295

(3032057) Clostridioides difficile [Presence] in Stool

0.70

0.26

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.70

0.26

1.0

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

169

1.18

0.25

2.6

3.1

mg/l

7.0

7.6

0.19

134

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

132

1.21

0.25

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

123

1.22

0.25

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

550

1.09

0.25

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

685

1.08

0.25

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

116

1096

1.06

0.23

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

727

1.07

0.23

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

846

0.93

0.22

1.1

u/ml

6.0

0.01

442

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

235

2264

1.04

0.22

6.0

3.5

mmol/l

1.1

1.7

2.06

159

1675

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.27

0.22

1.6

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.27

0.22

1.6

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.22

0.22

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

461.5

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

8.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

135

1.19

0.21

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

691

1.07

0.21

1.5

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

23.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.24

0.21

2.6

2.0

umol/l

13.3

16.2

0.74

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

198

0.86

0.20

1.4

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

383

1.10

0.20

1.2

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

810

0.94

0.20

1.1

u/ml

0.7

1.3

0.65

341

(40768800) Prostate Pathology biopsy report

732

1.07

0.20

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.22

0.20

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

111

0.81

0.20

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

0.80

0.20

1.3

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

0.80

0.20

1.3

2.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.21

0.19

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

156

1.15

0.18

5.9

3.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

204

1.13

0.18

1.2

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

204

1.13

0.18

1.1

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

166

1.15

0.18

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

785

0.94

0.18

1.1

u/ml

1.2

1.8

0.48

193

(44806420)

1.21

0.17

2.8

2.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.13

0.17

1.7

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

340

1.09

0.16

1.3

nmol/l

1.2

1.5

0.78

307

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.20

0.16

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

206

1.12

0.16

1.1

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

283

1.10

0.15

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.14

0.15

1.6

2.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

306

0.91

0.14

1.5

1.8

—

(3017569) Oxygen content in Arterial blood

180

0.89

0.13

1.5

2.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

814

1.05

0.13

4.0

2.9

umol/l

30.8

35.2

1.29

697

(3006270) Folate [Moles/volume] in Blood

335

0.92

0.13

1.2

1.1

nmol/l

411.8

387.7

0.23

297

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

272

0.92

0.12

1.4

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

181

1.11

0.12

1.4

1.1

u/l

17.9

28.2

0.49

139

(3051387) C reactive protein [Mass/volume] in Capillary blood

844

0.96

0.12

2.9

3.4

mg/l

20.4

27.4

1.39

514

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

189

0.90

0.12

1.6

2.2

ug/l

22.1

63.1

0.50

173

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

356

1.07

0.11

1.4

36.9

30.4

0.40

214

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

384

0.94

0.11

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

182

1.10

0.11

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

192

1.09

0.10

2.5

3.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

358

1.06

0.10

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

672

1.04

0.10

1.1

iu/ml

14.8

14289.2

0.54

164

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.14

0.10

1.0

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.09

1.0

—

(3019174) dRVVT (LA screen)

1.11

0.09

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

131

1276

1.03

0.09

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

281

1.07

0.09

1.6

2.0

u/field

1.8

2.0

0.07

125

(3006442) Creatine [Moles/volume] in Serum or Plasma

281

1.07

0.09

1.8

1.5

—

68.7

—

(3000285) Sodium [Moles/volume] in Blood

1.06

0.09

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.04

0.09

1.4

1.7

—

7.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

625

1.04

0.09

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

171

1675

1.02

0.08

1.5

1.7

mg/l

3.1

4.0

0.77

117

1173

(3022313) Gas panel - Capillary blood

167

1705

0.98

0.08

6.7

3.5

—

(3044007) Cell count panel - Peritoneal fluid

107

1.12

0.08

1.5

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

185

1.08

0.08

1.6

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

845

0.97

0.08

1.3

—

(3019977) pH of Arterial blood

205

0.93

0.08

1.6

2.9

7.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.03

0.07

7.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.84

0.07

2.0

1.6

—

(3002619) Bacteria identified in Specimen by Culture

0.86

0.07

1.9

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

934

0.97

0.07

1.1

u/ml

2.9

1.5

0.40

374

(4015189)

0.88

0.06

6.1

2.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

325

0.95

0.06

1.2

1.4

promille

1.3

0.04

258

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

264

0.95

0.06

1.4

mmol/l

5.3

5.6

0.90

255

(4211845)

217

1.06

0.06

2.4

3.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

425

0.96

0.05

3.9

5.9

mmol/l

7.1

0.02

360

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

159

1.07

0.05

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

110

0.91

0.05

1.9

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

414

0.97

0.05

3.3

1.9

ug/l

33.6

25.3

0.37

409

(3029396) Erythrocyte agglutination [Presence] in Blood

150

1.07

0.04

3.1

2.9

—

(3042631) Mycobacterium sp identified in Specimen

467

1.03

0.04

3.6

2.7

—

(3034426) Prothrombin time (PT)

149

0.94

0.03

1.1

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

994

0.99

0.03

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

612

0.98

0.03

1.0

1.1

u/ml

5.1

3.5

0.28

247

(4133840)

108

0.93

0.03

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

211

1.04

0.03

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

147

1456

1.01

0.02

1.9

1.8

—

(3008898) HLA-B27 [Presence]

160

1614

0.99

0.02

1.1

—

(3023419) Bacteria identified in Sputum by Culture

480

1.02

0.02

3.0

2.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

359

0.97

0.02

1.3

e6/l

132671.7

74662.9

0.19

246

(3000012) Reticulocyte production index

193

1.04

0.01

1.3

1.5

—

(3015183) Erythrocyte sedimentation rate

254

1.02

0.00

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

188

1.01

0.00

1.4

2.2

—

(3022689) Creatine [Moles/volume] in Urine

115

1.04

0.00

1.9

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

215

1.02

0.00

1.3

1.4

nmol/l

128.1

133.5

0.26

215

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

455

1.01

0.00

1.5

1.6

48.0

59.3

0.92

282

(3014133) Dog dander IgE Ab [Units/volume] in Serum

665

1.01

0.00

1.1

u/ml

2.0

3.4

0.81

253

(3023383) Lactate [Moles/volume] in Pleural fluid

1.04

0.00

1.3

1.4

mmol/l

3.2

3.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

126

1.03

0.00

1.0

—

(3033799) Differential panel - Peritoneal fluid

113

0.97

0.00

1.6

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

147

1.02

0.00

3.3

11.8

—

(3035880) pH of Pleural fluid

183

0.98

0.00

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.94

0.00

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.94

0.00

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3003129) Base excess in Capillary blood by calculation

0.93

0.00

2.0

1.8

mmol/l

1.3

0.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

87.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.99

0.00

1.1

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

71.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.93

0.00

6.4

8.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

28.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.96

0.00

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.98

0.00

1.0

1.4

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

119.9

—

(3024869) Neuronal Ab [Presence] in Serum

0.91

0.00

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1556.7

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

2680.9

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(44806071)

0.97

0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_TRUNK and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_TRUNK	0.926 [0.8, 1.07]	0.288
Birth year	0.996 [0.99, 1.0]	0.388

During the follow-up period (1.1.1998 — 31.12.2019), 609 out of 12216 females with CD2_BENIGN_MELANOCYTIC_TRUNK died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_TRUNK	1.086 [0.94, 1.25]	0.248
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1132 out of 10088 males with CD2_BENIGN_MELANOCYTIC_TRUNK died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_TRUNK.

N-year risk	Females	Males
1	0.11%	0.207%
5	0.616%	1.207%
10	1.534%	3.084%
15	2.884%	5.662%
20	5.105%	9.699%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_TRUNK – Melanocytic naevi of trunk

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi of trunk

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints